SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-059966
Filing Date
2024-05-10
Accepted
2024-05-10 16:50:25
Documents
4
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 tm2413608-1_pre14a.htm PRE 14A 719354
2 GRAPHIC lg_transcodetheraptm-4c.jpg GRAPHIC 10109
3 GRAPHIC px_2024transcode01pg1-bw.jpg GRAPHIC 293333
4 GRAPHIC px_2024transcode01pg2-bw.jpg GRAPHIC 229305
  Complete submission text file 0001104659-24-059966.txt   1423375
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40363 | Film No.: 24935734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)